_id
6915fad7bc934aba376b26e7
Ticker
SMDPY
Name
Sumitomo Pharma Co. Ltd
Exchange
PINK
Address
6-8, Doshomachi 2-chome, Osaka, Japan, 541-0045
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.sumitomo-pharma.com
Description
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Last Close
11.45
Volume
-
Current Price
11.45
Change
0
Last Updated
2026-01-07T11:58:07.730Z
Image
-
Ipo Date
-
Market Cap
7456881664
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
807747136
Cost Of Revenue
309136871
Gross Profit
498610264
Operating Expenses
340763237
Operating Income
157847026
Interest Expense
-
Pretax Income
548375679
Net Income
594377665
Eps
1.4960814307449561
Dividends Per Share
29.22
Shares Outstanding
397289648
Income Tax Expense
-46001985
EBITDA
584165548
Operating Margin
19.541638585271322
Total Other Income Expense Net
390528652
Cash
260622270
Short Term Investments
-
Receivables
861719199
Inventories
560348038
Total Current Assets
1835717913
Property Plant Equipment
304289535
Total Assets
5270704540
Payables
284700545
Short Term Debt
27084673
Long Term Debt
-
Total Liabilities
3472363476
Equity
1798341063
Bs_currency_symbol
-
Depreciation
35789870
Change In Working Capital
-134221825
Cash From Operations
125550279
Capital Expenditures
7186229
Cash From Investing
220299596
Cash From Financing
-325295907
Net Change In Cash
119025123
Cf_currency_symbol
-
PE
6.3855
PB
2.529534893682178
ROE
33.051442645059595
ROA
11.277005957916966
FCF
118364050
Fcf Percent
0.14653601941090633
Piotroski FScore
3
Health Score
78
Deep Value Investing Score
6
Defensive Investing Score
5.5
Dividend Investing Score
3.5
Economic Moat Investing Score
10
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
8
Net Net Investing Score
4
Quality Investing Score
8.5
Value Investing Score
8
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
807747136
Quarters > 0 > income Statement > cost Of Revenue
309136871
Quarters > 0 > income Statement > gross Profit
498610264
Quarters > 0 > income Statement > operating Expenses
340763237
Quarters > 0 > income Statement > operating Income
157847026
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
548375679
Quarters > 0 > income Statement > net Income
594377665
Quarters > 0 > income Statement > eps
1.4960814307449561
Quarters > 0 > income Statement > dividends Per Share
29.22
Quarters > 0 > income Statement > shares Outstanding
397289648
Quarters > 0 > income Statement > income Tax Expense
-46001985
Quarters > 0 > income Statement > EBITDA
584165548
Quarters > 0 > income Statement > operating Margin
19.541638585271322
Quarters > 0 > income Statement > total Other Income Expense Net
390528652
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
260622270
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
861719199
Quarters > 0 > balance Sheet > inventories
560348038
Quarters > 0 > balance Sheet > total Current Assets
1835717913
Quarters > 0 > balance Sheet > property Plant Equipment
304289535
Quarters > 0 > balance Sheet > total Assets
5270704540
Quarters > 0 > balance Sheet > payables
284700545
Quarters > 0 > balance Sheet > short Term Debt
27084673
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3472363476
Quarters > 0 > balance Sheet > equity
1798341063
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
594377665
Quarters > 0 > cash Flow > depreciation
35789870
Quarters > 0 > cash Flow > change In Working Capital
-134221825
Quarters > 0 > cash Flow > cash From Operations
125550279
Quarters > 0 > cash Flow > capital Expenditures
7186229
Quarters > 0 > cash Flow > cash From Investing
220299596
Quarters > 0 > cash Flow > cash From Financing
-325295907
Quarters > 0 > cash Flow > net Change In Cash
119025123
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.4960814307449561
Quarters > 0 > ratios > PB
2.529534893682178
Quarters > 0 > ratios > ROE
33.051442645059595
Quarters > 0 > ratios > ROA
11.277005957916966
Quarters > 0 > ratios > FCF
118364050
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.14653601941090633
Quarters > 0 > health Score
78
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
108002000000
Quarters > 1 > income Statement > cost Of Revenue
44112000000
Quarters > 1 > income Statement > gross Profit
63890000000
Quarters > 1 > income Statement > operating Expenses
43490000000
Quarters > 1 > income Statement > operating Income
20400000000
Quarters > 1 > income Statement > interest Expense
8468000000
Quarters > 1 > income Statement > pretax Income
11932000000
Quarters > 1 > income Statement > net Income
11206000000
Quarters > 1 > income Statement > eps
28.206096302449094
Quarters > 1 > income Statement > dividends Per Share
1000000
Quarters > 1 > income Statement > shares Outstanding
397290000
Quarters > 1 > income Statement > income Tax Expense
726000000
Quarters > 1 > income Statement > EBITDA
26241000000
Quarters > 1 > income Statement > operating Margin
18.88853910112776
Quarters > 1 > income Statement > total Other Income Expense Net
-8468000000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
20453000000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
83380000000
Quarters > 1 > balance Sheet > inventories
89751000000
Quarters > 1 > balance Sheet > total Current Assets
256718000000
Quarters > 1 > balance Sheet > property Plant Equipment
46103000000
Quarters > 1 > balance Sheet > total Assets
733333000000
Quarters > 1 > balance Sheet > payables
39308000000
Quarters > 1 > balance Sheet > short Term Debt
50188000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
557100000000
Quarters > 1 > balance Sheet > equity
176233000000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
11206000000
Quarters > 1 > cash Flow > depreciation
5203000000
Quarters > 1 > cash Flow > change In Working Capital
-7848000000
Quarters > 1 > cash Flow > cash From Operations
-1328802
Quarters > 1 > cash Flow > capital Expenditures
1474000000
Quarters > 1 > cash Flow > cash From Investing
-29856527
Quarters > 1 > cash Flow > cash From Financing
22278201
Quarters > 1 > cash Flow > net Change In Cash
-12983567
Quarters > 1 > cash Flow > currency_symbol
JPY
Quarters > 1 > ratios > PE
28.206096302449094
Quarters > 1 > ratios > PB
0.02581225139446074
Quarters > 1 > ratios > ROE
6.358627498822582
Quarters > 1 > ratios > ROA
1.5280916036780017
Quarters > 1 > ratios > FCF
-1475328802
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.013660198903724005
Quarters > 1 > health Score
29
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
105649000000
Quarters > 2 > income Statement > cost Of Revenue
39671000000
Quarters > 2 > income Statement > gross Profit
65978000000
Quarters > 2 > income Statement > operating Expenses
50400000000
Quarters > 2 > income Statement > operating Income
15578000000
Quarters > 2 > income Statement > interest Expense
21993000000
Quarters > 2 > income Statement > pretax Income
-6415000000
Quarters > 2 > income Statement > net Income
2415000000
Quarters > 2 > income Statement > eps
6.0786830778524505
Quarters > 2 > income Statement > dividends Per Share
1000000
Quarters > 2 > income Statement > shares Outstanding
397290000
Quarters > 2 > income Statement > income Tax Expense
-8830000000
Quarters > 2 > income Statement > EBITDA
5604000000
Quarters > 2 > income Statement > operating Margin
14.745052011850563
Quarters > 2 > income Statement > total Other Income Expense Net
-21993000000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
23116000000
Quarters > 2 > balance Sheet > short Term Investments
16840000000
Quarters > 2 > balance Sheet > receivables
74840000000
Quarters > 2 > balance Sheet > inventories
94222000000
Quarters > 2 > balance Sheet > total Current Assets
253168000000
Quarters > 2 > balance Sheet > property Plant Equipment
46648000000
Quarters > 2 > balance Sheet > total Assets
742604000000
Quarters > 2 > balance Sheet > payables
38544000000
Quarters > 2 > balance Sheet > short Term Debt
46440000000
Quarters > 2 > balance Sheet > long Term Debt
258982000000
Quarters > 2 > balance Sheet > total Liabilities
573125000000
Quarters > 2 > balance Sheet > equity
169479000000
Quarters > 2 > balance Sheet > currency_symbol
JPY
Quarters > 2 > cash Flow > net Income
2415000000
Quarters > 2 > cash Flow > depreciation
5807000000
Quarters > 2 > cash Flow > change In Working Capital
-733000000
Quarters > 2 > cash Flow > cash From Operations
11009000000
Quarters > 2 > cash Flow > capital Expenditures
2375000000
Quarters > 2 > cash Flow > cash From Investing
2311000000
Quarters > 2 > cash Flow > cash From Financing
-63535000000
Quarters > 2 > cash Flow > net Change In Cash
-62277000000
Quarters > 2 > cash Flow > currency_symbol
JPY
Quarters > 2 > ratios > PE
6.0786830778524505
Quarters > 2 > ratios > PB
0.026840909493211548
Quarters > 2 > ratios > ROE
1.42495530419698
Quarters > 2 > ratios > ROA
0.32520697437665297
Quarters > 2 > ratios > FCF
8634000000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.08172344272070725
Quarters > 2 > health Score
40
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
112434000000
Quarters > 3 > income Statement > cost Of Revenue
41439000000
Quarters > 3 > income Statement > gross Profit
70995000000
Quarters > 3 > income Statement > operating Expenses
49590000000
Quarters > 3 > income Statement > operating Income
21405000000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
56432000000
Quarters > 3 > income Statement > net Income
53448000000
Quarters > 3 > income Statement > eps
134.53145057766366
Quarters > 3 > income Statement > dividends Per Share
1000000
Quarters > 3 > income Statement > shares Outstanding
397290000
Quarters > 3 > income Statement > income Tax Expense
2984000000
Quarters > 3 > income Statement > EBITDA
27471000000
Quarters > 3 > income Statement > operating Margin
19.037835530177706
Quarters > 3 > income Statement > total Other Income Expense Net
35027000000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
85393000000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
94323000000
Quarters > 3 > balance Sheet > inventories
107426000000
Quarters > 3 > balance Sheet > total Current Assets
333688000000
Quarters > 3 > balance Sheet > property Plant Equipment
52613000000
Quarters > 3 > balance Sheet > total Assets
852115000000
Quarters > 3 > balance Sheet > payables
49278000000
Quarters > 3 > balance Sheet > short Term Debt
254960000000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
686000000000
Quarters > 3 > balance Sheet > equity
166115000000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
53448000000
Quarters > 3 > cash Flow > depreciation
6066000000
Quarters > 3 > cash Flow > change In Working Capital
183000000
Quarters > 3 > cash Flow > cash From Operations
939000000
Quarters > 3 > cash Flow > capital Expenditures
2057000000
Quarters > 3 > cash Flow > cash From Investing
-8000000
Quarters > 3 > cash Flow > cash From Financing
-15865000000
Quarters > 3 > cash Flow > net Change In Cash
85393000000
Quarters > 3 > cash Flow > currency_symbol
JPY
Quarters > 3 > ratios > PE
134.53145057766366
Quarters > 3 > ratios > PB
0.02738446558107335
Quarters > 3 > ratios > ROE
32.175300243807
Quarters > 3 > ratios > ROA
6.272392810829524
Quarters > 3 > ratios > FCF
-1118000000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
-0.009943611363110803
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
398832000000
Annuals > 0 > income Statement > cost Of Revenue
153437000000
Annuals > 0 > income Statement > gross Profit
245395000000
Annuals > 0 > income Statement > operating Expenses
216591000000
Annuals > 0 > income Statement > operating Income
28804000000
Annuals > 0 > income Statement > interest Expense
13500000000
Annuals > 0 > income Statement > pretax Income
17611000000
Annuals > 0 > income Statement > net Income
23634000000
Annuals > 0 > income Statement > eps
59.48803141282187
Annuals > 0 > income Statement > dividends Per Share
3000000
Annuals > 0 > income Statement > shares Outstanding
397290000
Annuals > 0 > income Statement > income Tax Expense
-6024000000
Annuals > 0 > income Statement > EBITDA
56673000000
Annuals > 0 > income Statement > operating Margin
7.222088498415373
Annuals > 0 > income Statement > total Other Income Expense Net
-11193000000
Annuals > 0 > income Statement > currency_symbol
JPY
Annuals > 0 > balance Sheet > cash
23116000000
Annuals > 0 > balance Sheet > short Term Investments
16840000000
Annuals > 0 > balance Sheet > receivables
74840000000
Annuals > 0 > balance Sheet > inventories
94222000000
Annuals > 0 > balance Sheet > total Current Assets
253168000000
Annuals > 0 > balance Sheet > property Plant Equipment
46648000000
Annuals > 0 > balance Sheet > total Assets
742604000000
Annuals > 0 > balance Sheet > payables
38544000000
Annuals > 0 > balance Sheet > short Term Debt
46440000000
Annuals > 0 > balance Sheet > long Term Debt
258982000000
Annuals > 0 > balance Sheet > total Liabilities
573125000000
Annuals > 0 > balance Sheet > equity
169479000000
Annuals > 0 > balance Sheet > currency_symbol
JPY
Annuals > 0 > cash Flow > net Income
23635000000
Annuals > 0 > cash Flow > depreciation
25562000000
Annuals > 0 > cash Flow > change In Working Capital
-18770000000
Annuals > 0 > cash Flow > cash From Operations
16500000000
Annuals > 0 > cash Flow > capital Expenditures
13030000000
Annuals > 0 > cash Flow > cash From Investing
99754000000
Annuals > 0 > cash Flow > cash From Financing
-108836000000
Annuals > 0 > cash Flow > net Change In Cash
-5931000000
Annuals > 0 > cash Flow > currency_symbol
JPY
Annuals > 0 > ratios > PE
59.48803141282187
Annuals > 0 > ratios > PB
0.026840909493211548
Annuals > 0 > ratios > ROE
13.94509054219107
Annuals > 0 > ratios > ROA
3.1825845268810835
Annuals > 0 > ratios > FCF
3470000000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.008700405183134753
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
314558000000
Annuals > 1 > income Statement > cost Of Revenue
126577000000
Annuals > 1 > income Statement > gross Profit
187981000000
Annuals > 1 > income Statement > operating Expenses
542175000000
Annuals > 1 > income Statement > operating Income
-354194000000
Annuals > 1 > income Statement > interest Expense
4277000000
Annuals > 1 > income Statement > pretax Income
-323114000000
Annuals > 1 > income Statement > net Income
-314969000000
Annuals > 1 > income Statement > eps
-792.7896861754075
Annuals > 1 > income Statement > dividends Per Share
2792000000
Annuals > 1 > income Statement > shares Outstanding
397292000
Annuals > 1 > income Statement > income Tax Expense
-8185000000
Annuals > 1 > income Statement > EBITDA
-281072000000
Annuals > 1 > income Statement > operating Margin
-112.60053789762144
Annuals > 1 > income Statement > total Other Income Expense Net
31745000000
Annuals > 1 > income Statement > currency_symbol
JPY
Annuals > 1 > balance Sheet > cash
29047000000
Annuals > 1 > balance Sheet > short Term Investments
7085000000
Annuals > 1 > balance Sheet > receivables
81023000000
Annuals > 1 > balance Sheet > inventories
115350000000
Annuals > 1 > balance Sheet > total Current Assets
269569000000
Annuals > 1 > balance Sheet > property Plant Equipment
57895000000
Annuals > 1 > balance Sheet > total Assets
907506000000
Annuals > 1 > balance Sheet > payables
38544000000
Annuals > 1 > balance Sheet > short Term Debt
289298000000
Annuals > 1 > balance Sheet > long Term Debt
133367000000
Annuals > 1 > balance Sheet > total Liabilities
751370000000
Annuals > 1 > balance Sheet > equity
156063000000
Annuals > 1 > balance Sheet > currency_symbol
JPY
Annuals > 1 > cash Flow > net Income
-314929000000
Annuals > 1 > cash Flow > depreciation
37765000000
Annuals > 1 > cash Flow > change In Working Capital
-95847000000
Annuals > 1 > cash Flow > cash From Operations
-241893000000
Annuals > 1 > cash Flow > capital Expenditures
15730000000
Annuals > 1 > cash Flow > cash From Investing
33036000000
Annuals > 1 > cash Flow > cash From Financing
77851000000
Annuals > 1 > cash Flow > net Change In Cash
-114431000000
Annuals > 1 > cash Flow > currency_symbol
JPY
Annuals > 1 > ratios > PE
-792.7896861754075
Annuals > 1 > ratios > PB
0.029148442616122976
Annuals > 1 > ratios > ROE
-201.82170021081228
Annuals > 1 > ratios > ROA
-34.70709835527258
Annuals > 1 > ratios > FCF
-257623000000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.818999993641872
Annuals > 1 > health Score
15
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
555544000000
Annuals > 2 > income Statement > cost Of Revenue
178919000000
Annuals > 2 > income Statement > gross Profit
376625000000
Annuals > 2 > income Statement > operating Expenses
453604000000
Annuals > 2 > income Statement > operating Income
-76979000000
Annuals > 2 > income Statement > interest Expense
3159000000
Annuals > 2 > income Statement > pretax Income
-47920000000
Annuals > 2 > income Statement > net Income
-74512000000
Annuals > 2 > income Statement > eps
-187.54971154717438
Annuals > 2 > income Statement > dividends Per Share
11125000000
Annuals > 2 > income Statement > shares Outstanding
397292000
Annuals > 2 > income Statement > income Tax Expense
48794000000
Annuals > 2 > income Statement > EBITDA
-3498000000
Annuals > 2 > income Statement > operating Margin
-13.85650821537088
Annuals > 2 > income Statement > total Other Income Expense Net
29059000000
Annuals > 2 > income Statement > currency_symbol
JPY
Annuals > 2 > balance Sheet > cash
143478000000
Annuals > 2 > balance Sheet > short Term Investments
20174000000
Annuals > 2 > balance Sheet > receivables
95908000000
Annuals > 2 > balance Sheet > inventories
94405000000
Annuals > 2 > balance Sheet > total Current Assets
381860000000
Annuals > 2 > balance Sheet > property Plant Equipment
58909000000
Annuals > 2 > balance Sheet > total Assets
1134742000000
Annuals > 2 > balance Sheet > payables
13403000000
Annuals > 2 > balance Sheet > short Term Debt
95248000000
Annuals > 2 > balance Sheet > long Term Debt
244128000000
Annuals > 2 > balance Sheet > total Liabilities
727960000000
Annuals > 2 > balance Sheet > equity
406749000000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-96714000000
Annuals > 2 > cash Flow > depreciation
41263000000
Annuals > 2 > cash Flow > change In Working Capital
34878000000
Annuals > 2 > cash Flow > cash From Operations
11937000000
Annuals > 2 > cash Flow > capital Expenditures
12742000000
Annuals > 2 > cash Flow > cash From Investing
52419000000
Annuals > 2 > cash Flow > cash From Financing
-146817000000
Annuals > 2 > cash Flow > net Change In Cash
-59506000000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-187.54971154717438
Annuals > 2 > ratios > PB
0.0111837850861342
Annuals > 2 > ratios > ROE
-18.318914121485243
Annuals > 2 > ratios > ROA
-6.56642655334869
Annuals > 2 > ratios > FCF
-805000000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.0014490301398269083
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
560035000000
Annuals > 3 > income Statement > cost Of Revenue
157127000000
Annuals > 3 > income Statement > gross Profit
402908000000
Annuals > 3 > income Statement > operating Expenses
342674000000
Annuals > 3 > income Statement > operating Income
60234000000
Annuals > 3 > income Statement > interest Expense
3050000000
Annuals > 3 > income Statement > pretax Income
82961000000
Annuals > 3 > income Statement > net Income
56413000000
Annuals > 3 > income Statement > eps
141.99344060932359
Annuals > 3 > income Statement > dividends Per Share
11126000000
Annuals > 3 > income Statement > shares Outstanding
397293000
Annuals > 3 > income Statement > income Tax Expense
42361000000
Annuals > 3 > income Statement > EBITDA
124359000000
Annuals > 3 > income Statement > operating Margin
10.75539921612042
Annuals > 3 > income Statement > total Other Income Expense Net
22727000000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
202984000000
Annuals > 3 > balance Sheet > short Term Investments
35596000000
Annuals > 3 > balance Sheet > receivables
151407000000
Annuals > 3 > balance Sheet > inventories
99021000000
Annuals > 3 > balance Sheet > total Current Assets
499521000000
Annuals > 3 > balance Sheet > property Plant Equipment
64091000000
Annuals > 3 > balance Sheet > total Assets
1308007000000
Annuals > 3 > balance Sheet > payables
22455000000
Annuals > 3 > balance Sheet > short Term Debt
30548000000
Annuals > 3 > balance Sheet > long Term Debt
243963000000
Annuals > 3 > balance Sheet > total Liabilities
634438000000
Annuals > 3 > balance Sheet > equity
607888000000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
40600000000
Annuals > 3 > cash Flow > depreciation
38348000000
Annuals > 3 > cash Flow > change In Working Capital
-33733000000
Annuals > 3 > cash Flow > cash From Operations
31239000000
Annuals > 3 > cash Flow > capital Expenditures
13494000000
Annuals > 3 > cash Flow > cash From Investing
-18278000000
Annuals > 3 > cash Flow > cash From Financing
-21426000000
Annuals > 3 > cash Flow > net Change In Cash
9286000000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
141.99344060932359
Annuals > 3 > ratios > PB
0.007483294373305608
Annuals > 3 > ratios > ROE
9.280163451162055
Annuals > 3 > ratios > ROA
4.312897408041394
Annuals > 3 > ratios > FCF
17745000000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.03168551965502156
Annuals > 3 > health Score
38
Valuation > metrics > PE
6.3855
Valuation > metrics > PB
2.529534893682178
Valuation > final Score
100
Valuation > verdict
18.1% Undervalued
Profitability > metrics > ROE
33.051442645059595
Profitability > metrics > ROA
32.378485865981744
Profitability > metrics > Net Margin
0.7358462054639833
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
1.9308703712783986
Risk > metrics > Interest Coverage
4.4103828935501275
Risk > final Score
48
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.88776441928687
Liquidity > metrics > Quick Ratio
4.090539901734533
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
66.15268443706108
Prev Valuations > 1
90
Prev Valuations > 2
40
Prev Profitabilities > 0
41
Prev Profitabilities > 1
9
Prev Profitabilities > 2
100
Prev Risks > 0
16
Prev Risks > 1
9
Prev Risks > 2
9
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
65
Updated At
2026-01-20T22:35:22.006Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-11
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-01-29
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-10-28
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
1.4961
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-07-29
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
JPY
Earnings History > 3 > eps Actual
0.1952
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-03-31
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0399
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-01-31
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
JPY
Earnings History > 5 > eps Actual
0.8829
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-10-30
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
JPY
Earnings History > 6 > eps Actual
-0.8124
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-07-31
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
JPY
Earnings History > 7 > eps Actual
0.2574
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-05-14
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
JPY
Earnings History > 8 > eps Actual
-3.3441
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-01-31
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
JPY
Earnings History > 9 > eps Actual
-0.8504
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-09-30
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
JPY
Earnings History > 10 > eps Actual
-0.5028
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-06-30
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
JPY
Earnings History > 11 > eps Actual
-0.7113
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-03-31
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
JPY
Earnings History > 12 > eps Actual
-1.0648
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2022-12-31
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
JPY
Earnings History > 13 > eps Actual
-0.1997
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATrump’s 100% drug tariffs send pharma stocks lower (GSK:NYSE) Seeking Alpha
Read more →(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Sumitomo Pharma Co. Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
1.4961
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.